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1. Introduction 
N-Glycan biosynthesis is complex and involves many enzymes in the endoplasmic 
reticulum (ER) and the Golgi apparatus, but small numbers of enzymes found in the 
Golgi apparatus are responsible for branching and extending, as well as for sialylation 
(1). In mammals, sialic acids usually serve as the terminal monosaccharides of the 
glycans in glycoproteins and glycolipids (2,3). β-Galactoside α2,3-sialyltransferase1 
(ST3GAL1) and ST3GAL2-6 and β-galactoside α2,6-sialyltransferase 1 (ST6GAL1) 
and ST6GAL2 in the Golgi apparatus are responsible for the syntheses of 
Neu5Ac(α2,3)Gal and Neu5Ac(α2,6)Gal (4), as shown in Table 1. ST3GAL1 and 
ST3GAL2 are almost exclusively used in the type III disaccharide Galβ1-3GalNAc that 
is found in O-glycans and glycolipids (5). ST3GAL5 is almost exclusively used in 
lactosyl-ceramide as an acceptor substrate for GM3 production, which also is known as 
GM3-synthase (6). In particular, ST3GAL3, ST3GAL4, and ST3GAL6 are known to be 
involved in the synthesis of N-glycans terminated with Neu5Ac(α2,3)Gal (7). On the 
other hand, ST6GAL1 appears to play an important role in the synthesis of N-glycans 
terminated with Neu5Ac(α2,6)Gal in many kinds of cells and tissues (8-10). There is 
ample evidence that sialic acids are important bioinformatic molecules, which play 
pivotal roles in biological, pathological, and immunological processes through 
modifying glycoproteins and glycolipids on the cell surface, including nervous system 
embryogenesis (11), cell-cell interactions (12,13), signal transduction (14), and bacterial 
and viral infection (15,16), etc.  
Table 1. Specific acceptor structures and carrier types for each α2,3- or 
α2,6-sialyltransferases (17). 
Sialyltransferases Acceptor structure(s)/(Carrier Type) 
ST3Gal I Galβ1-3GalNAc, Galβ1-3GlcNAc/(O-glycans, glycolipids) 
ST3Gal II Galβ1-3GalNAc/(O-glycans, glycolipids) 
ST3Gal III Galβ1-3*/4GlcNAc(N-glycans, O-glycans, glycolipids) 
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ST3Gal IV 
Galβ1-3GalNAc, Galβ1-3/4*GlcNAc/(N-glycans, O-glycans, 
glycolipids) 
ST3Gal V Galβ1-4Glc/(glycolipids) 
ST3Gal VI Galβ1-3/4*GlcNAc/(N-glycans, O-glycans, glycolipids) 
ST6Gal I Galβ1-4GlcNAc/(N-glycans) 
ST6Gal II Galβ1-4GlcNAc/(N-glycans) 
ST6GalNAc I Galβ1-3GalNAc/(O-glycans) 
ST6GalNAc II Galβ1-3GalNAc/(O-glycans) 
ST6GalNAc III Galβ1-3GalNAc, GM1b/(O-glycans, glycolipids) 
ST6GalNAc IV Galβ1-3GalNAc, GM1b/(O-glycans, glycolipids) 
ST6GalNAc V GM1b/(glycolipids) 
ST6GalNAc VI GM1b, GT1b/(glycolipids) 
  
In addition, sialic acids on cell membranes are closely related to tumor invasion and 
metastasis (18,19). Many studies have shown that the expression of ST6GAL1 is 
increased in diverse carcinomas, which may highly correlate with tumor progression. 
For example, ST6GAL1 regulates macrophage apoptosis by controlling the 
α2,6-sialylation of tumor necrosis factor receptor-1 (20). ST6GAL1 is up-regulated in 
colon carcinoma, and its metastasis and poor prognosis is ascribed to sialylation of the 
Fas death receptor by ST6GAL1 that provides protection against Fas-mediated 
apoptosis (21). Moreover, differentiation of human dendritic cells is accompanied by an 
increased expression of sialylated glycans, mainly through the activities of ST3GAL1 
and ST6GAL1 (22). However, among the six enzymes of α2,3-sialyltransferases, 
ST3GAL3, ST3GAL4, and ST3GAL6 participate mainly in the generation of 
NeuAcα2,3Galβ3/4GlcNAc, which is the precursor of sLea or sLex (23,24), two 
important tumor-associated sialylated glycoconjugates (25-27). In fact, the increased 
sialylation and expressions of these sialyltransferases genes in cervical cancer were also 
reported (28-32). Therefore, study of the expression and biological functions of 
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ST3GAL3, ST3GAL4, and ST3GAL6 in tumors is of great importance. In fact, before 
this study, we screened several cell lines (HeLa, MDA-MB-231, MiaPaCa2, PANC-1, 
HuH-7, 293T, CW-2, PMF-ko14, Hep G2) as shown in Fig. 1A to determine a cell line 
suitable to investigate the roles of α2,3-sialylation. we found that the expression levels 
of mRNA for α2,3-sialyltransferases (ST3GAL3, ST3GAL4 and ST3GAL6) in HeLa 
cells were relatively higher, while α2,6-sialyltransferase (ST6GAL1) was relatively 
lower than those in the other eight cell lines (Fig. 1A). So, we chose the HeLa cell line 
as a suitable cell model to study.  
Until now, several reports have chronicled the functions of these cells in various types 
of tumors. For example, the expression of ST3GAL3 has been associated with tumor 
progression, differentiation and metastasis in extrahepatic cholangiocarcinoma (33), and 
secondary tumor recurrence in gastric cancer (34). ST3GAL6 is known to promote cell 
adhesion and migration of multiple myeloma cells by increasing the synthesis of 
selectin ligands, and a knockdown of ST3GAL6 has reduced the ability of multiple 
myeloma cells to home in the bone marrow, which prolonged the rate of survival in a 
xenograft mouse model (35). On the other hand, there has been no consensus on the 
clinical significance of ST3GAL4. Some researchers reported a decrease in ST3GAL4 
mRNA expression in gastrointestinal and ovarian cancer (36,37), while others have 
shown significant increases in cervical intraepithelial neoplasia, colorectal cancer, and 
pancreatic adenocarcinoma tissues (38-40). These different phenomena are yet to be 
clearly explained. ST3GAL3, ST3GAL4, and ST3GAL6 show a similar enzymatic 
substrate specificity in catalyzing the transfer of sialic acid on the terminal Gal residue 
of the disaccharide Galβ1-3/4GlcNAc of glycoproteins (41), which makes it plausible 
that the α2,3-sialylation modification of glycoproteins represents a co-involvement 
and/or a compensation. As mentioned above, the tissue and tumor-specific expressions 
of these enzymes have been extensively reported either by comparing their contents in 
cancer tissues, as well as in the tissues adjacent to cancers (42-44), or by investigating 
their overexpressions or the knockdown of a single gene (35,40,45). Such approaches, 
 4 
 
however, are insufficient to explain the biological functions of α2,3-sialylation, and its 
underlying molecular mechanisms.  
To distinguish the respective functions of ST3GAL3, ST3GAL4, and ST3GAL6, we 
used the clustered, regularly interspaced, short palindromic repeats/caspase-9 
(CRISPR/Cas-9) system (46) to establish individual gene knockout (KO) HeLa cell 
lines, and restored the KO cells with the same or different genes in order to compare 
their functions. We found that the three enzymes differed in their modification of the 
α2,3-sialylation of target proteins and in the distinct biological functions each plays in 
cell adhesion, cell growth, and colony formation.  
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2. Materials and methods 
2.1 Antibodies and reagents 
The experiments were performed with the following antibodies: rabbit mAbs against 
Claudin-1 (#13255T), epidermal growth factor receptor (EGFR) (#3777), ERK1/2 
(#4695S), phospho-ERK1/2 (#4370S), AKT (#9272), and phospho-AKT (#4060) were 
obtained from Cell Signaling Technology; mouse mAbs against E-cadherin (#610182), 
N-cadherin (#610920) and β1 integrin (#610468) were from BD Biosciences; mouse 
mAbs against ɑ-tubulin (#T6199) and FLAG (#F1804) was from MilliporSigma; rabbit 
mAbs against GAPDH (FL-335, #SC-25778) were from Santa Cruz Biotechnology, Inc. 
Alexa Fluor® 647 goat anti-mouse IgG and streptavidin were obtained from Thermo 
Fisher Scientific; Alexa Fluor® 488 conjugated anti-mouse (#A11029) was from 
Invitrogen; Alexa FluorTM 568 phalloidin (#A12380) and TO-PRO-3 (#T3605) was from 
Molecular Probes. The peroxidase-conjugated secondary antibody against rabbit 
(#7074S) was obtained from Cell Signaling Technology; peroxidase-conjugated 
secondary antibodies against mouse (#AP124P) was from MilliporeSigma; Maackia 
amurensis (MAM) lectin (#BA-s7801-2) was from EY Laboratories, Inc; Concanavalin 
A (ConA) lectin (#B-1005) from Seikagaku Corporation; MAM-Agarose (J310) and 
SSA-Agarose (J318) was from J-OIL MILLS, Inc. An ABC kit was acquired from 
Vector Laboratories; doxycycline hyclate (DOX) (#D9891) was from Sigma-Aldrich；
PrimeScript™ RT reagent Kit with gDNA Eraser (Perfect Real Time)(#RR047A) was 
from Takara; Quick Taq ® HS DyeMix (DTM-101) was from TOYOBO. 
. 
2.2 Cell Lines and cell culture 
The HeLa and 293T cell lines (RIKEN Cell Bank, Tsukuba, Japan) were cultured at 
37 °C in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum 
(FBS), in a humidified atmosphere containing 5% CO2, except for the virus production. 
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2.3 Genomic deletion of ST3GAL3, ST3GAL4 or ST3GAL6 in HeLa cells 
The pSpCas9(BB)-2A-GFP (PX458) plasmid and pSpCas9(BB)-2A-Puro (PX459) V2.0 
plasmid were purchased from Addgene (PX458:Addgene plasmid #48138, 
PX459:Addgene plasmid #62988) and were deposited by Dr. Feng Zhang (46). The 
target site on human ST3GAL4 exon 8 (TTGAACAATGCCCCAGTGGC) as 
previously described (47), was cloned into PX458. The target site on human ST3GAL3 
exon 8 (TGCCGCCGCTGCATCATCGT) and ST3GAL6 exon 5 
(CTATGGGATGAGAACATCAG), which were designed by guide design tool 
(https://zlab.bio/guide-design-resources/), were cloned into PX459. The three kinds of 
KO cell lines were created by electroporating cells with the vectors containing the target 
sequences, according to the manufacturer’s recommendations (Amaxa cell line 
Nucleofector kit; Lonza, Basel, Switzerland). One day post-transfection, the cells 
transfected with ST3GAL3 KO or ST3GAL6 KO plasmid and were selected with 
1µg/ml puromycin for 48 h. After further incubation for five days, the cells were 
subjected to fluorescence activated cell sorting (FACS) to isolate low MAM binding 
transfectants. Stable KO cells were cloned by a limiting dilution. For isolation of 
ST3GAL4 KO cells, 3 days post-transfection, the cells were subjected to FACS to 
isolate cells that highly expressed GFP. Stable clones were isolated by a limiting 
dilution. The α2,3-sialylation levels were confirmed by flow cytometry and Western 
blotting using MAM lectin. 
  
2.4 ST3GAL3, ST3GAL6 and GFP-tagged E-cadherin expression vectors 
We used the Gateway™ cloning system from Invitrogen for all overexpression 
experiments. The cDNAs of human ST3GAL3 and ST3GAL6 were kindly provided by 
Dr. H. Narimatsu (National Institute of Advanced Industrial Science and Technology, 
Japan). The Gateway entry vectors were constructed as described previously (48). In 
brief, using LR clonase (Invitrogen), the sub-cloned cDNAs in entry vectors were 
transferred into CSIV-TRE-RfA-CMV-KT for the doxycycline hyclate inducible 
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overexpression. To express GFP-tagged E-cadherin, expression vector 
pEGFP-N1-E-cadherin–GFP was transfected using PEI MAX (molecular mass, 40 kDa; 
Polysciences Inc.) as previously described (49). 
 
2.5 Virus production and infection 
The virus production and infection was performed as described previously (48,50,51). 
Briefly, ST3GAL4 overexpression viruses were prepared as previously described (48). 
To prepare the ST3GAL3 and ST3GAL6 overexpression viruses, the lentivirus vectors 
(CSIV-TRE-RfA-CMV-KT) were transfected into 293T cells with packaging plasmids 
via PEI MAX. The target cells were cultured for 24 h to obtain virus media for infection. 
After infection for 72 h, cells were selected using FACSAria II (BD bioscience) to 
obtain Kusabira Orange-positive cells (CSIV-TRE-RfA-CMV-KT). Stable clones were 
also isolated using a limiting dilution. The stable cells that expressed Kusabira 
Orange-positive in fluorescence microscopy were chosen and used in subsequent 
studies. 
 
2.6 Western bot and immunoprecipitation 
Western blot and Immunoprecipitation was performed as described previously with 
minor modifications (48,49). In brief, the indicated cells were rinsed twice with ice-cold 
PBS and then lysed in a cell lysate buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% 
Triton X-100) that included protease and phosphatase inhibitors (Nacalai Tesque, Kyoto, 
Japan) for 30 min. The protein concentrations of lysates were determined via BCA assay 
(Pierce). Equal amounts of cell lysates from each sample were resolved by SDS-PAGE. 
Then, the proteins were transferred to PVDF membranes (MilliporeSigma) and detected 
with primary and secondary antibodies, and visualized by the Immobilon Western 
Chemiluminescent HRP Substrate (MilliporeSigma), according to the manufacturer’s 
instructions. For immunoprecipitates, equal amounts of protein lysates from each 
sample were immunoprecipitated with MAM-agarose or Sambucus sieboldiana 
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Agglutinin (SSA)-agarose, which specifically recognizes α2,3 or α2,6 sialylation, 
respectively, for 1 h at 4 °C with rotation, and then the immunoprecipitates were washed 
twice with lysis buffer and subjected to SDS-PAGE. The precipitated glycoproteins 
were detected using different antibodies. 
 
2.7 Cell growth and colony formation analysis 
The cell growth curves and colony formation assays were performed as described 
previously with minor modifications (52,53). In brief, to assay cell growth, the cells (5 
× 104) were seeded in 6-well culture dishes overnight and then serum-starved for 24 h. 
After starvation, the cells were supplied with DMEM containing 10% FBS. Cells in the 
same areas on the cultured dishes were photographed and counted at the indicated times 
(0, 24, 48, and 72 h), the folds of change in cell numbers were normalized to those at 0 
h and statistically analyzed. To assay the colony formation, Cells (500/per well) were 
seeded in 6-cm dishes in DMEM containing 10% FBS, incubated at 37 °C and the 
cultured media were changed twice weekly. After incubation for 14 days, the formed 
colonies were stained with 0.25% crystal violet, and images were taken. Colonies 
containing more than 50 cells were counted and analyzed statistically from three 
independent wells of each sample. 
 
2.8 Flow cytometry analysis  
Flow cytometric analysis was performed as described previously with minor 
modifications (54,55). Briefly, the indicated semi-confluent cells were detached from 
the culture dishes using trypsin containing 1 mM EDTA and were subsequently stained 
with or without the primary biotinylated MAM, followed by incubation with Alexa 
Fluor 647-conjugated streptavidin. After washing three times with PBS, flow cytometric 
analysis was performed using a FACSCalibur flow cytometer and Cell Quest Pro 
software (BD Biosciences). 
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2.9 Immunofluorescence 
Immunofluorescence staining was performed as described previously with minor 
modifications (52,53). In brief, Cells were cultured on glass-bottom dishes, rinsed twice 
with PBS and fixed with 4% paraformaldehyde for 20 min. A nonspecific blocking 
solution was applied (PBS, 0.1% Triton X-100, 10% BSA) at room temperature for 1 h. 
N-cadherin antibodies were used and followed by incubation with anti-mouse Alexa 
Fluor 488 secondary antibodies (Invitrogen) and Alexa Fluor 568 phalloidin 
(Invitrogen), and then incubated with TO-PRO-3 for 20 min in the dark. After 
transfection for 48 h, those cells overexpressed GFP-tagged E-cadherin were rinsed 
twice with PBS and fixed with 4% paraformaldehyde for 20 min, and incubated with 
TO-PRO-3 for 20 min in the dark. Fluorescence images were observed via confocal 
microscopy using a FluoView FV1000 (Olympus, Tokyo, Japan). 
 
2.10 RT-PCR for mRNA Expression Analysis 
The cDNA of nine kinds of cells was provided by previous work in our laboratory. For 
detection of E-cad mRNA level and cell KO confirmation, total RNA was prepared with 
TRI reagent (Invitrogen), and 1μg of total RNA was reverse-transcribed using a 
PrimeScript RT reagent kit with gDNA Eraser (Takara) according to the manufacturer’s 
instructions. The primers for KO confirmation were designed around the knockout 
region. The sequences of the primers used for the PCR amplification were shown in 
Table 2. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as 
a control in PCR runs, and the reaction products obtained were subjected to 
electrophoresis using 2% agarose gels containing ethidium bromide. 
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Gene 
names 
Sense primer (5’–3’) Antisense primer (5’–3’) 
Annealing 
temperature (℃) 
I. Primers for detection of expression levels 
ST3GAL1 GACTTGGAGTGGGTGGTGAG ACAAGTCCACCTCATCGCAG 57  
ST3GAL2 CTCTCGGGCAAGAGCTGTG CTGCAGCATCATCCACCACC 59  
ST3GAL3 CTATGACATTGTGGTGAGACTGA CTCTCTCCTTGTAGACGATGTATTT 51  
ST3GAL4 TGAGGGTGGCCCGAGG CCGGGAGTAGTTGCCAAAGA 59  
ST3GAL5 CCAATGCCAAGTGAGTACACC TGAGCTCTCTTTACATGGTCAGG 57  
ST3GAL6 AGGTGGCTGTTGGAATTGT GTTGTTGGGTGTTTAGGTTTCTG 51  
ST6GAL1 GAAAAATGGGCCTTGGCCTG GAGCAGGAAAACAAGCCTGC 57  
E-cadherin CGTAGCAGTGACGAATGTGGTAC  AACTGGAGAACCATTGTCTGTAGC  59  
GAPDH CGGAGTCAACGGATTTGGTCGTA  AGCCTTCTCCATGGTGGTGAAGAC  57  
II. Primers for KO confirmation 
ST3GAL3 CCGCCGCTGCATCATCGT  TGCACTCACTCTCTCCTTGTAGAC  68  
ST3GAL4 GAACAATGCCCCAGTGGC  GGGTTGAGAATCCGAATCTGTTTAG  66  
ST3GAL6 CCCTATGGGATGAGAACATCAG  TAGGGTCATTGTGAATAGGATCTG  66  
Table 2.  Primer sequences and annealing temperatures for RT-PCR 
 
2.11 Cell aggregation assay 
Cell aggregation assay was performed as described previously (56). Briefly, Cells (2 × 
105 cells/ml) were resuspended in DMEM containing 1% BSA with or without 2 mM 
EDTA. For each condition, 1 ml of the cell suspension was added to a 15-ml tube, 
which was followed by incubation in a rotator (MACSmixTube Rotator; Miltenyi 
Biotec, Bergisch-Gladbach, Germany) at 12 rpm for 6 h at 37 °C. The cell suspensions 
were placed in 6-well plates and the field of vision was randomly selected for 
photography. Cell aggregation assays were performed using three independent wells for 
each sample. 
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2.12 Statistical analysis 
All data are expressed as the mean ± standard derivation. Statistical analyses were 
performed using either a Student's t test or one-way analysis of variance (ANOVA) by 
GraphPad Prism version 5 (GraphPad Software, La Jolla, CA, USA). Statistical 
significance was defined as p< 0.05 (*p < 0.05; **p < 0.01; ***p < 0.001). 
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3. Results 
3.1 Knockouts of the ST3GAL3, ST3GAL4, or ST3GAL6 genes reduced 
α2,3-sialylation  
To determine what kind of cells are more suitable for establishing KO cell lines, we 
detected the mRNA levels of α2,3-sialyltransferases (ST3GAL1-6) and 
α2,6-sialyltransferase (ST6GAL1) in 9 kinds of cells (including Hela, MDA-MB-231, 
MiaPaCa2, PANC-1, HuH-7, 293T, CW-2, PMF-ko14 and Hep G2), We found that the 
mRNA levels of the α2,3-sialyltransferases (ST3GAL3, ST3GAL4 and ST3GAL6) in 
Hela cells were higher than that in other 8 kinds of cells, while α2,6-sialyltransferases 
(ST6GAL1) was lower (Fig. 1A). So we thouth Hela cells are more suitable for 
establishing KO cell lines. And to distinguish the specific functions of the three 
α2,3-sialyltransferases of ST3GAL3, ST3GAL4, and ST3GAL6, we established each 
single KO cell line using the CRISPR/Cas9 system. As expected, flow cytometric 
analysis using MAM lectin, which specifically recognizes α2,3-sialylated galactose, 
showed that the α2,3-sialylation levels were decreased in the ST3GAL3-, ST3GAL4-, 
and ST3GAL6-KO cells, compared with that in the wild type (WT) cells. The degree of 
decrease in α2,3-sialylation seemed to be as follows: ST3GAL4 KO > ST3GAL3 KO > 
ST3GAL6 KO (Fig. 1B). The MAM lectin blot showed a similar tendency (Fig. 1C). 
There were no significant differences in the reactive abilities of ConA lectin, which 
preferentially recognizes high-mannose types of N-glycans, for either the three KO cells 
or WT cells (Fig. 1D). Compared with normal primers and GAPDH, the RT-PCR results 
used with the primers for KO confirmation were significantly lower in three KO cells 
than that in WT cells (Fig. 1E). It indicated that the bases in the KO regions of three 
groups of KO cells have been changed. These results suggested that the knockouts of 
the ST3GAL3, ST3GAL4, and ST3GAL6 genes were successful. 
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Fig 1. Selection of Knockout Cell Lines and abatement of ɑ2,3-Sialylation in 
ST3GAL3, ST3GAL4, or ST3GAL6 KO cells.  
A) The mRNA levels of α2,3-sialyltransferases (ST3GAL1-6) and α2,6-sialyltransferase 
(ST6GAL1) in 9 kinds of cells were detected by RT-PCR, GAPDH was used as a 
control. B) The sequences of the primers used for the PCR amplification were shown. C) 
WT and three kinds of KO HeLa cells were collected and incubated with (bold line) or 
without (grey shadow) MAM lectin, which specifically recognizes sialic acid ɑ2,3 
galactose, followed by incubation with Alexa Fluor 647 streptavidin subjected to flow 
cytometric analysis. The vertical dashed line indicates the peak reacted with MAM 
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lectin in WT cells. Equal amounts of cell lysates from WT and the three types of KO 
cells were immunoblotted with MAM lectin (C) and ConA lectin (D), which 
preferentially recognizes high-mannose N-glycans. α-Tubulin was used as a loading 
control. E) The primers for KO confirmation designed around the knockout region were 
used to confirm knock-out of these enzymes in WT and three kinds of KO cells by 
RT-PCR. The normal primers and GAPDH were used as controls. 
 
3.2 Comparing cell proliferation and cellular signaling among the ST3GAL3-, 
ST3GAL4-, and ST3GAL6-KO cells  
We used these KO cell lines to compare cell biological functions. First, we investigated 
the effects of α2,3-sialyltransferase KO on cell proliferation, and found that cell growth 
was significantly suppressed in the ST3GAL3 KO and ST3GAL6 KO cells, but not in 
the ST3GAL4 KO cells, compared with the WT cells (Fig. 2A). It is notable that the cell 
growth for ST3GAL4 KO cells seemed to demonstrate a cell density-dependent manner, 
i.e., when cells were cultured at a much lower density, the growth rate of ST3GAL4 KO 
cells was lower than that of the WT cells, but once cells reached a certain density the 
growth rate of ST3GAL4 KO cells was significantly increased at a rate that was even 
faster than that of the WT cells (Fig. 2A). To confirm those phenomena, a clonogenic 
assay was conducted to test the single-cell potential for survival and ‘unlimited’ cell 
division (53,57). The ST3GAL3 and ST3GAL6 KO cells consistently formed smaller 
and fewer foci, compared with those in the WT cells (Fig. 2B, 2C). Interestingly, the 
numbers of foci in ST3GAL4 KO cells were similar to those in the WT cells, but the 
foci seemed smaller than those in the WT cells (Fig. 2B, 2C), which may support the 
notion again that cell growth exists in a cell density-dependent manner in the ST3GAL4 
KO cells. Western blotting was used to detect the activation of ERK and AKT that is 
related to cell proliferation and survival, we found that the phosphorylation levels of 
ERK were decreased significantly in ST3GAL6 KO cells (Fig. 2D, 2E), while the 
phosphorylation levels of AKT were significantly decreased in ST3GAL3 KO cells (Fig. 
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2D, 2F), compared with WT or ST3GAL4 KO cells. Together, these results clearly 
indicated that ST3GAL3, ST3GAL4, and ST3GAL6 differ in their effect on cell 
functions via distinct mechanisms. 
 
Fig 2. Effects of ST3GAL3-, ST3GAL4-, and ST3GAL6-KO on cell proliferation 
and cellular signaling. 
A) WT and the three kinds of KO cells were seeded in 6-well culture dishes overnight 
and then serum-starved for 24 h. After starvation, the cells were supplied with DMEM 
containing 10% FBS, which was taken as the 0 point (0 h), and further incubated for 72 
h. The cells in the same areas on the cultured dishes were photographed and counted at 
the indicated times (0, 24, 48, and 72 h), the fold changes in the cell numbers were 
normalized to those at 0 h. Data are represented as the mean ± standard derivation (n = 3 
individual experiments). B, C) WT and the three kinds of cells (500/per well, suspended 
in a single cell) were grown for 14 days, and then stained with crystal violet and the foci 
in each well were counted. B) Representative images for colony formation. C) The 
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stained colonies were counted, and quantitative data are presented as the means ± 
standard derivation from three independent experiments. D) The expression levels of 
phosphorylated and total ERK and AKT in the four cells were examined by Western 
blotting with the indicated antibodies. GAPDH was used as a loading control. E) 
Relative ratios of pERK/ERK in these four cells were quantified (n = 3 independent 
experiments). F) Relative ratios of pAKT/AKT in these four cells were quantified (n = 3 
independent experiments). All values are the means ± standard derivation, one-way 
ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. 
 
3.3 Deletion of ST3GAL3, ST3GAL4, or ST3GAL6 genes altered cell morphology 
and induced cell aggregation  
Next, we noticed cell morphological changes after deletion of the three genes. The KO 
cells all tended to form islands, which were never observed in the WT cells. Among 
them, ST3GAL3 KO cells were the most obvious, followed by ST3GAL6 KO cells, 
while the effect in ST3GAL4 KO cells was much weaker. Immunofluorescent staining 
of F-actin showed that the ST3GAL3 KO cells and ST3GAL6 KO cells exhibited 
cortical actin around the cell surface, while ST3GAL4 KO cells did not (Fig. 3A). We 
attempted to perform immunostaining with E-cadherin antibody, but failed. Instead of 
E-cadherin, immunostaining with N-cadherin was carried out. N-cadherin was highly 
expressed in the cell-cell contacts in ST3GAL3 KO and ST3GAL6 KO cells, which 
existed in a diffuse state in the cytoplasm and in the cell surface in ST3GAL4 KO and 
WT cells (Fig. 3A). Furthermore, we performed a cell aggregation assay in the 
suspension. The three KO cells all tended to form many aggregates, whereas the WT 
cells remained as either single cells or as much smaller aggregates (Fig. 3B). Those cell 
aggregates disappeared in the presence of EDTA, suggesting that the cell-cell adhesion 
had proceeded in a calcium-dependent manner. To better understand the underlying 
molecular mechanisms, we compared the expression levels of some adhesive molecules, 
which affect cell-cell adhesion, such as claudin-1, E-cadherin, and N-cadherin. It was 
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interesting that the expressions of claudin-1 and E-cadherin, which promote cell-cell 
adhesion, were greatly increased in ST3GAL3 KO and ST3GAL6 KO cells, but were 
decreased in ST3GAL4 KO cells (Fig. 3C). On the other hand, the expression levels of 
N-cadherin were similar in all cells (Fig. 3C). To further determine the changes of 
E-cadherin expression in four groups of cells, we performed an overexpression system 
with GFP-tagged human E-cadherin. The ST3GAL3 KO and ST3GAL6 KO cells 
expressed more E-cadherin on the cell surface, compared to the WT cells and ST3GAL4 
KO cells (Fig. 3D). In addition, E-cadherin proteins seemed to be internalized in the 
ST3GAL4 KO cells. We also used RT-PCR to detect the E-cad mRNA level in WT and 
3 kinds of KO cells, and found that E-cad not only changed the protein level, but also 
the mRNA level (Fig. 3E). These results again indicated that ST3GAL3, ST3GAL4, and 
ST3GAL6 differ in their effect on cell morphology via different pathways. 
 
Fig 3. Knockout of ST3GAL3, ST3GAL4, or ST3GAL6 in HeLa cells, altered cell 
morphologies, and induced cell aggregation.  
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A) WT and the three kinds of KO cells were stained with anti-N-cadherin antibody, 
followed by incubation with fluorescent secondary antibody. Localization of F-actin was 
examined by staining with Alexa Fluor 568 phalloidin, and the nucleus by TO-PRO-3. B) 
The four kinds of cells were detached from culture dishes and suspended at 2×105 
cells/ml in 10% FBS culture medium with or without EDTA, followed by constant 
rotation (12 rpm) for 6 h at 37 °C. An aliquot of each of these cell suspensions was 
photographed with a phase-contrast microscope. C) The same amounts of cell lysates 
from the four cells were examined by Western blotting with the indicated antibodies, 
and α-tubulin was used as a loading control. D) Fluorescence images of WT and the 
three kinds of KO cells overexpressed with E-cadherin-GFP, and the nucleus stained by 
TO-PRO-3. E) The E-cad mRNA level in WT and 3 kinds of KO cells were detected by 
RT-PCR. GAPDH was used as a control. 
 
3.4 Restoration of ST3GAL3, ST3GAL4, or ST3GAL6 genes in each of the 
corresponding KO cells rescued ɑ2,3-sialylation, cell morphology, and expression 
of E-cadherin  
Given the observations described in Figs. 2 and 3, we attempted to determine if the 
phenotypes could be rescued by the restoration of each gene in the corresponding KO 
cells (RES). The α2,3-sialylation levels were compared between the KO and RES cells 
using flow cytometry and Western blotting. As expected, increased α2,3-sialylation was 
observed in each of the RES cells by either flow cytometric analysis (Fig. 4A) or 
Western blotting with MAM lectin (Fig. 4B). The cell morphologies that tended to form 
aggregations in the KO cells were reversed to separated or small aggregation 
morphologies in each of the RES cells, particularly in the ST3GAL3 RES or ST3GAL6 
RES cells (Fig. 4C). Although the restoration of ST3GAL4 did not signal a significant 
change in E-cadherin expression, the enhanced E-cadherin expression levels observed in 
the ST3GAL3 KO and ST3GAL6 KO cells shown in Fig. 3C were greatly suppressed in 
the ST3GAL3 RES and ST3GAL6 RES cells (Fig. 4D). These results further supported 
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the notion that ST3GAL3, ST3GAL4, and ST3GAL6 differ in their effect on cell 
morphology. 
 
Fig 4. Forced expression of ST3GAL3, ST3GAL4, or ST3GAL6 KO genes in each 
of the corresponding KO cells, and the rescued cell morphologies and E-cadherin 
expressions.  
Each KO cells and restoration of each gene in the corresponding KO (RES) cells were 
cultured in the presence of DOX at 1µg/ml for 72 h before the following experiments 
were performed. A) The KO and RES cells were collected and incubated with (bold line) 
or without (gray shadow) MAM lectin, followed by incubation with Alexa Fluor 647 
streptavidin and subjected to flow cytometric analysis. The vertical dashed lines indicate 
the peaks reacted with MAM lectin in KO cells. B) Equal amounts of cell lysates from 
these KO and RES cells were examined by immunoblot with MAM lectin and anti-Flag 
antibodies. GAPDH was used as a loading control. C) Representative cell morphologies 
of each KO and RES cells were taken with a phase-contrast microscope. Arrows 
indicated cell aggregation. D) The same amounts of cell lysates from each KO and RES 
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cells were analyzed by Western blotting with the E-cadherin antibody, and α-tubulin was 
used as a loading control. 
 
3.5 ST3GAL3, ST3GAL4, or ST3GAL6 modified target glycoproteins differently  
Sialylation is well known to play an important role in cancer cell invasion and 
metastasis, as well as in cell growth. Here, we chose three representative 
transmembrane glycoproteins, β1 integrin, EGFR and N-cadherin to detect the changes 
in α2,3-sialylation and α2,6-sialylation levels in the KO cells. Of particular interest, the 
α2,3-sialylation levels of β1 integrin were only decreased in the ST3GAL4 KO cells, 
compared with those in the WT cells. Conversely, the α2,3-sialylation levels were 
increased in the ST3GAL3 KO and ST3GAL6 KO cells (Fig. 5A, D). The underlying 
mechanisms for the enhancement remain unclear, but it is reasonable that the KOs of 
ST3GAL3 and ST3GAL6 genes would decrease a competitor for a common donor 
substrate, CMP-NANA, which could relatively increase the amounts of CMP-NANA 
available for ST3GAL4 to catalyze the α2,3-sialylation of β1 integrin. However, the 
α2,3-sialylation levels of EGFR were only decreased in the ST3GAL6 KO cells, but not 
in the other two KO cells (Fig. 5B, E). Curiously, the changes in the α2,3-sialylation of 
N-cadherin were similar among the three KO cells (Fig. 5C, F). On the other hand, the 
changes in the α2,6-sialylation of the target proteins, with the exception of EGFR in the 
ST3GAL6 KO cells, were the opposite (Fig. 5), suggesting that these 
α2,3-sialyltransferases may compete with ST6GAL1 for the same substrates. These 
results strongly suggest that ST3GAL3, ST3GAL4, and ST3GAL6 differ in their 
regulation of biological functions via the modification of different target glycoproteins, 
i.e., each enzyme has preferential target proteins.  
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Fig 5. Knockout of ST3GAL3, ST3GAL4, or ST3GAL6 in HeLa cells differed in 
the alteration of the levels of α2,3-sialylation and α2,6-sialylation of specific 
glycoproteins.  
Equal amounts of cell lysates were immunoprecipitated with MAM-agarose or 
Sambucus sieboldiana Agglutinin (SSA)-agarose which specifically recognizes 
α2,6-sialylation, for 1 h at 4°C with rotation, and then the immunoprecipitates were 
washed twice with lysis buffer and subjected to SDS-PAGE. The precipitated 
glycoproteins and cell lysates were immunoblotted for β1 integrin (A), EGFR antibody 
(B), and N-cadherin (C) antibodies. The relative levels of α2,3 and α2,6 sialylation on 
β1 integrin (D), EGFR (E) and N-cadherin (F) in these four kinds of cells, were 
quantified (n = 3 independent experiments). All values are the means ± standard 
derivation, one-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. 
 
3.6 Cross-restoration using ST3GAL3, ST3GAL4, or ST3GAL6 genes in 
ST3GAL6 KO cells differed in the rescued α2,3-sialylation and cell morphology  
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To further confirm the specificities of the three α2,3-sialyltransferases, we performed a 
cross-restoration with ST3GAL3, ST3GAL4, or ST3GAL6 genes in the ST3GAL6 KO 
cells. The efficiencies for rescuing the α2,3-sialylation levels in the ST3GAL6 RES 
cells, examined using flow cytometry, were clearly higher than those in the cells 
expressed with ST3GAL3 or ST3GAL4 (Fig. 6A), which was further confirmed by 
lectin blotting with MAM lectin (Fig. 6B). The expression levels of each 
α2,3-sialyltransferase were similar among these cells, as confirmed by Western blotting 
with anti-Flag antibody (Fig. 6B). In addition, the cell aggregations induced by 
ST3GAL6 deficiency were efficiently rescued to normal cell morphology, as with WT 
cells, by overexpression of ST3GAL6, but neither ST3GAL3 nor ST3GAL4 
overexpression had the same effect (Fig. 6C). These results clearly indicated that the 
overexpressions of ST3GAL3 or ST3GAL4 could not completely rescue the decreased 
α2,3-sialylation levels and functions caused by ST3GAL6 deletion, further suggesting 
that these three enzymes have preferential target proteins. 
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Fig 6. Restoration of either ST3GAL3 or ST3GAL4 genes could not completely 
rescue the α2,3-sialylation levels and cell morphologies of impaired ST3GAL6 KO 
cells.  
The ST3GAL6 KO cells transfected with or without ST3GAL3, ST3GAL4, or 
ST3GAL6 genes were cultured in the presence of DOX at 1µg/ml for 72 h before the 
following experiments were performed. A) These four kinds of cells were collected and 
incubated with (bold line) or without (gray shadow) MAM lectin, followed by 
incubation with Alexa Fluor 647 streptavidin and subjected to flow cytometric analysis. 
The vertical dashed lines indicate the peaks of the reaction abilities with MAM lectin in 
the ST3GAL6 KO cells rescued with or without ST3GAL6 genes. B) Equal amounts of 
cell lysates were examined by immunoblotting with MAM lectin and anti-flag antibody. 
α-Tubulin was used as a loading control. C) Representative cell morphologies of these 
four kinds of cells were taken with a phase-contrast microscope. Arrows indicated cell 
aggregation. 
 
3.7 Cross-restoration with ST3GAL3, ST3GAL4, or ST3GAL6 genes in the 
ST3GAL6 KO cells differ in the rescue levels of α2,3-sialylation and 
α2,6-sialylation on target glycoproteins 
Again, the α2,3-sialylation and α2,6-sialylation levels of β1 integrin, EGFR, and 
N-cadherin were tested following cross-restoration with ST3GAL3, ST3GAL4, or 
ST3GAL6 genes in ST3GAL6 KO cells. The increases in α2,3-sialylation and decreases 
in α2,6-sialylation of β1 integrin were much more obvious in the cells restored with the 
ST3GAL4 gene compared with those restored using the other versions (Fig. 7A, D), 
while both the α2,3-sialylation and α2,6-sialylation of EGFR that were down-regulated 
in the KO of the ST3GAL6 gene were preferentially rescued by an overexpression of 
ST3GAL6, but not by overexpressions of either ST3GAL3 or ST3GAL4 (Fig. 7B,E). 
Curiously, consistent with the data shown in Fig. 5B, the expression of ST3GAL6 
seemed correlated with both α2,3- and α2,6-sialylation of EGFR. Compared with the 
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other two genes, restoration with the ST3GAL6 gene in the ST3GAL6 KO cells 
efficiently increased α2,3-sialylation levels and decreased the α2,6-sialylation levels of 
N-cadherin (Fig. 7C). These results further clearly demonstrated that the three enzymes 
have individual specific target proteins, and that ST3GAL4 is the most critical for the 
α2,3-sialylation of β1 integrin, while ST3GAL6 is the most important for the 
α2,3-sialylation of EGFR. 
 
Fig 7. The cross-restoration of ST3GAL3, ST3GAL4, or ST3GAL6 in ST3GAL6 
KO cells differed in the alteration of sialylation in target proteins.  
As described in Fig.6, the ST3GAL6 KO cells transfected with or without ST3GAL3, 
ST3GAL4, or ST3GAL6 genes, were cultured in complete medium with 1µg/ml DOX 
for 72 h before the following experiments were performed. Equal amounts of cell 
lysates as indicated were immunoprecipitated with MAM-agarose or SSA-agarose for 1 
h at 4 °C with rotation, and then the immunoprecipitates were washed twice with lysis 
buffer and subjected to SDS-PAGE. The precipitated glycoproteins and cell lysates were 
immunoblotted for β1 integrin (A), EGFR (B), or N-cadherin (C) antibodies. The 
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relative levels of α2,3- and α2,6-sialylation on β1 integrin (D), EGFR (E) and 
N-cadherin (F) in these four kinds of cells, were quantified (n = 3 independent 
experiments). All values are reported the means ± standard derivation (error bars), 
one-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. 
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4. Discussion 
In the present study, we used the same HeLa cell line to investigate the functions of 
three α2,3-sialyltransferases, ST3GAL3, ST3GAL4, and ST3GAL6, which are the most 
important sialyltransferases for the α2,3-sialylation of N-glycans. We found that 1) the 
three α2,3-sialyltransferases had different functions in cell proliferation and cell 
adhesion, as well as in cellular signaling; 2) the three α2,3-sialyltransferases 
individually promote specific modifications for different target proteins (Fig. 8), for 
example, ST3GAL4 modifies β1 integrin, while ST3GAL6 modifies EGFR; and, 3) the 
three α2,3-sialyltransferases show negligible levels of compensation for α2,3-sialylation, 
and may compete with ST6GAL1 for sialylation of the same target protein. Our studies 
are the first to characterize the α2,3-sialylation of the three enzymes in the same cell 
line, which may help us to understand their functional expressions, and explain some 
previous results or interpret some controversial observations obtained from different 
cells or tumor tissues (36,39,58). 
Glycan structures expressed on glycoproteins and glycolipids of cells are essential for 
regulating normal cell functions (59). Altered tumor-associated carbohydrate antigens 
have been identified in many solid tumors, and the changes in terminal sialylation are 
very important in malignant transformation and cancer progression (60,61). Until now, 
most studies have focused on either the effects of three kinds of sialylation linkages 
(α2,3, α2,6 and α2,8) in tumors or on the expression levels of certain sialyltransferases 
in tumors. Examples of these studies include the following: α2,3-sialylation of α2 
integrin has been related to the bone metastatic behavior of prostate cancer cells (61); 
malignant transformation of oral epithelium was found to be accompanied by 
α2,3-sialylation, wherein α2,6-sialylation was related to disease progression and 
metastatic potentials (62); melanoma progression has been associated with a significant 
increase in α2,3-sialylation on the surface (58); several sialyltransferase genes were 
found to be highly expressed in human colon and gastric tumor tissues (63,64); and, 
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important functions of a single sialyltransferase have been observed by manipulation of 
the gene expression in a cell line (40,45,65). However, very little is known about which 
sialyltransferase(s) is/are specifically responsible for the synthesis of these altered 
glycans on defined glycoproteins. The main function of these three enzymes is to 
modify the α2,3-sialylation of glycoproteins. As far as we could ascertain, few studies 
have compared the functions of these genes in the same cell line. The present study 
clearly demonstrated that ST3GAL4 in HeLa cells significantly contributes to total 
α2,3-sialylation levels, compared with the effect from either ST3GAL3 or ST3GAL6, 
but each sialyltransferase has its own specific target glycoproteins, which subsequently 
affects cellular signaling. ST3GAL4 KO significantly decreases the α2,3-sialylation of 
integrin β1, but not that of EGFR; ST3GAL6 KO, however, greatly decreases the 
α2,3-sialylation of EGFR, but not that of integrin β1. Consistently, the levels of p-ERK 
and cell proliferation were down regulated in ST3GAL6 KO cells, not in ST3GAL4 KO 
cells, compared with WT cells. Curiously, the levels of p-AKT were only suppressed in 
the ST3GAL3 KO cells, suggesting that ST3GAL3 might specifically modify some 
glycoproteins that promote AKT activation in order to regulate cell proliferation. Thus, 
we speculated that the ranges for the α2,3-sialylation of glycoproteins affected by 
ST3GAL3, ST3GAL4, and ST3GAL6 are different. In fact, the present results were 
supported by a previous study, which found that the sialylation of a recombinant 
glycoprotein, erythropoietin, was specifically modified by ST3GAL4, and not by either 
ST3GAL3 or ST3GAL6 in Chinese Hamster Ovary cells (7). An observation made in 
the present study whereby the α2,3-sialylation of integrin β1 was conversely increased 
in both the ST3GAL3 and ST3GAL6 KO cells could also be very important (Fig. 5A). 
Although the exact underlying mechanism in this novel result will require further 
studies, it would be plausible to speculate that a KO of either the ST3GAL3 or 
ST3GAL6 gene may relatively increase the amounts of a common donor substrate, 
CMP-NANA, which would allow ST3GAL4 to modify integrin β1, which further 
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suggests that the KO effect of a glycogene may be expressed as both a loss-of-function 
and a gain-of-function.  
The specificities of the three enzymes for their own target proteins were also proved by 
the cross-restoration experiments. Overexpression of either ST3GAL3 or ST3GAL4 in 
the ST3GAL6 KO cells increased the levels of α2,3-sialylation to some extent, but the 
recovery level observed in ST3GAL6 RES cells was never reached (Fig.6), suggesting 
ST3GAL6 has its own intrinsic target proteins, as described above. In fact, the 
restorative ability with respect to the α2,3-sialylation of integrin β1 was the highest in 
the ST3GAL4 RES cells, while that of the α2,3-sialylation of both EGFR and 
N-cadherin was the highest in the ST3GAL6 RES cells (Fig.7). Furthermore, cell 
morphology differed among the three cross-restoration cells, and only the 
overexpression of ST3GAL6 could rescue it to the level of WT cells. When the 
important functions of integrin β1 (66,67), EGFR (68), and N-cadherin (69) are 
considered, there can be little doubt that the three sialyltransferases differentially 
regulate cell biological functions, cancer progression, and tumor resistance. Of course, 
the specificities of the three enzymes give them a relative approach rather than an 
all-or-nothing effect. The overexpression of ST3GAL4 in the ST3GAL6 KO cells also 
slightly increased the α2,3-sialylation levels of EGFR, as ST3GAL6 did.  
Changes in the α2,6-sialylation levels of these KO cells merit recognition, since α2,3- 
and α2,6-sialyltranfserases may compete with common substrates to a certain extent, 
and this competition is manifested in specific glycoproteins such as β1 integrin. 
Interestingly, among all three genes, ST3GAL4 deficiency alone reciprocally increased 
the levels of α2,6-sialylation (Fig. 5), while the overexpression of ST3GAL4 conversely 
decreased the α2,6-sialylation levels of β1 integrin (Fig.7). Therefore, when evaluating 
the effect of α2,3-sialylation, the influences of α2,6-sialylation could not be neglected, 
since the α2,6-sialylation of β1 plays important roles in cell adhesion and cell 
proliferation (53,70). These results, could also partly explain the observation of different 
phenotypes in these three KO cells. Although the decrease in the α2,3-sialylation of β1 
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integrin was more obvious in the ST3GAL4 KO cells, the phenomena of cell-cell 
aggregation and cell proliferation were much weaker than that observed in the 
ST3GAL3 KO cells, which might have been due to the significant increase in the 
α2,6-sialylation of β1 integrin in the ST3GAL4 KO cells. In fact, the expression of 
ST6GAL1 is important for not only β1-mediated cell adhesion, but also for cellular 
signaling such as that seen in the PI3K-AKT signaling pathway (53,71). Our previous 
results showed that the up-regulation of α2,6-sialylation inhibited E-cadherin expression 
(72), which might partly explain why the expression levels of E-cadherin were 
increased in ST3GAL3 or ST3GAL6 KO cells, whereas it was decreased in the 
ST3GAL4 KO cells in the present study, although we could not identify whether the 
levels of sialylated E-cadherin changed after a KO of the three enzymes. Nevertheless, 
we did not exclude other possibilities that could affect E-cadherin expression.  
It is noteworthy that the down-regulation of α2,3-sialylation decreased the 
α2,6-sialylation of EGFR in the ST3GAL6 KO cells (Fig. 5) while up-regulation of 
α2,3-sialylation increased it (Fig. 7). Thus far, the details of this molecular mechanism 
remain unclear, but α2,3-sialylation could affect EGFR conformation changes, which 
could result in the promotion of ST6GAL1 accessibility to some glycosylation sites for 
α2,6-sialylation. In fact, EGFR contains12 potential N-glycosylation sites, and the 
N-glycans on EGFR have been reported to play important roles in receptor functions 
that include ligand binding and tyrosine kinase activity (73). For example, the 
Asn-420-Gln mutant EGFR did not bind to the EGF ligand, but spontaneously induced 
oligomerization, resulting in phosphorylation of the receptor in the absence of a ligand, 
further supporting the notion that glycans may be involved in maintaining the proper 
structure of target proteins (74). In addition, the sialylation on glycolipids and/or 
O-glycoproteins has also changed when the malignant degree of cells changed (75,76). 
Although ST3GAL3, ST3GAL4 and ST3GAL4 are the three most important transferases 
for the α2,3-sialylation of N-glycans, they are also involved in the modifications of 
glycolipids and/or O-glycoproteins (24,77,78). For example, intestinal Muc2 mucin 
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O-glycosylation is regulated by differential expression of glycosyltranferases( such as 
ST3GAL4, ST3GAL6 and ST6GAL1) (79); the α2,3-sialylation of O-glycans on selectin 
ligand is regulated by ST3GAL6 which influences homing and survival in multiple 
myeloma (35). So we will detect the effects of these three enzymes on sialylation of 
glycolipids and/or O-glycoproteins in future studies. 
Most sialytransferases modify proteins in the Golgi apparatus. Based on our results, we 
speculated that three α2,3-sialytransferases modify glycoproteins (β1, EGFR and 
N-cadherin) through different pathways or functional distinct Golgi units (Fig 8), which 
can also be referred to as the “zones” of mitochondria (80) or Golgi apparatus (81,82). 
Hiroyuki et al. agreed with our observations and reported that functional distinct Golgi 
units exist in Drosophila cells (83) to selectively modify target proteins such as Notch 
and GAG core proteins. Therefore, it is reasonable to postulate that distinct Golgi units 
containing different kinds of sialyltransferases exist in HeLa cells, and that the majority 
of β1 integrin or EGFR might be modified with α2,3-sialylation in the zones containing 
ST3GAL4 or ST3GAL6, respectively. ST6GAL1 might ubiquitously exist in those 
zones together with ST3GAL3, ST3GAL4, or ST3GAL6. In addition, the specificities 
for target protein modification might also depend on the acceptor structures, it is known 
that ST3GAL3 seems to prefer the Galβ1-3GlcNAc disaccharide whereas ST3GAL4 
and ST3GAL6 appear to prefer the Galβ1-4GlcNAc linkage (23,84,85). The detailed 
mechanisms will require further study. 
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Fig 8. The proposed mechanisms for the modification of α2,3-sialylation by 
ST3GAL3, ST3GAL4, and ST3GAL6 in glycoproteins expressed on the cell surface 
in different domains.  
All membrane glycoproteins such as β1 integrin, EGFR, and N-cadherin were 
synthesized in ribosomes and then transferred from the ER to the Golgi apparatus for 
oligosaccharide assembly, and then finally transported to the cell surface in different 
domains. The present study clearly supported the notion that there are distinct functional 
units, referred to as “zones”, in the Golgi apparatus (83), i.e., the α2,3-sialylation of β1 
integrin was mainly catalyzed in zones containing ST3GAL4, while the α2,3-sialylation 
of EGFR occurred in zones containing ST3GAL6. On the other hand, the 
α2,3-sialylation of N-cadherin was accomplished in zones containing ST3GAL3, 
ST3GAL4, and ST3GAL6. Furthermore, it is worth noting that ST6GAL1 could be 
ubiquitously distributed in all of those zones. These results clearly demonstrate that the 
three α2,3-sialyltransferases of ST3GAL3, ST3GAL4, and ST3GAL6 differed in their 
modification of target proteins and in their regulation of cell biological functions. 
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In conclusion, using knockout and cross-restoration techniques, we clearly 
demonstrated that ST3GAL3, ST3GAL4, and ST3GAL6 differ in their modification of 
target proteins and in their regulation of cell biological functions. Clarifying the 
specificities of the three sialyltransferases and the underlying molecular mechanisms 
will shed light on the biological functions of ST3GAL3, ST3GAL4, and ST3GAL6 in 
various tissues and cells, and could also provide insight into drug developments for 
cancer and infection therapies.  
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